Login / Signup

Pharmacokinetics, safety, and efficacy of an alternative dosing regimen of sasanlimab in participants with advanced NSCLC and other malignancies.

Konstantin PenkovIgor BondarenkoDaria Viktorovna SaenkoYaroslav KulyabaJun GuoYi GongNoboru YamamotoYevhen Stepanovych HotkoVasyl BoykoNatalya Vladimirovna FadeevaGrygorii Mykolaiovych UrsolHee Kyung AhnNikolay Viktorovich KislovChia-I ShenCraig DavisKarey KowalskiElisabete MichelonDmitri PavlovTomoko HirohashiByoung Chul Cho
Published in: Therapeutic advances in medical oncology (2024)
NCT04181788 (ClinicalTrials.gov); 2019-003818-14 (EudraCT).
Keyphrases
  • small cell lung cancer
  • advanced non small cell lung cancer
  • brain metastases
  • epidermal growth factor receptor
  • tyrosine kinase